Kang-Hyun Han
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kang-Hyun Han has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
- Yong-Bum Kim
Division of Next Generation Non-Clinical Research, Korea Institute of Toxicology , Daejeon 34114
6 shared publications Min Seong Jang
Division of Next Generation Non-Clinical Research, Korea Institute of Toxicology, Daejeon, Republic of Korea
5 shared publicationsSeung Eui Min
Division of Next Generation Non-Clinical Research, Korea Institute of Toxicology, Daejeon 34114, Republic of Korea; Human and Environmental Toxicology, University of Science and Technology, 217 Gajeong-ro, Yuseong-gu, Daejeon 34113, Republic of Korea
4 shared publications- Byung Sun Min
College of Pharmacy, Drug Research and Development Center, Daegu Catholic University, Gyeongbuk, 38430, Republic of Korea
3 shared publications Eun-Young Gu
Department of Advanced Toxicology Research, Korea Institute of Toxicology, Daejeon, Republic of Korea
3 shared publicationsJi-Min Park
Human and Environmental Toxicology, University of Science and Technology, Daejeon, Republic of Korea
3 shared publications
Latest Publications
- Open Access
- 30 June 2026
- Published by Elsevier in Journal of Chromatography B
- Vol. 1281, 125198
Development and application of a liquid chromatography–tandem mass spectrometry method for the analysis of Areca nut alkaloids in rat plasma for a toxicokinetic study
- 30 June 2026
- Published by Elsevier in Journal of Chromatography B
- Vol. 1281, 125198
Open AccessDevelopment and application of a liquid chromatography–tandem mass spectrometry method for the analysis of Areca nut alkaloids in rat plasma for a toxicokinetic study
- Open Access
- 18 May 2026
- Published by Elsevier in SSRN Electronic Journal
Development and Application of a Liquid Chromatography–Tandem Mass Spectrometry Method for the Analysis of Areca Nut Alkaloids in Rat Plasma for a Toxicokinetic Study
Areca nut (Areca catechu L., Arecaceae) contains bioactive alkaloids, including arecoline, arecaidine, and guvacoline, which are associated with pharmacological and toxicological effects. A rapid and sensitive ultra-performance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS) method was developed and validated for simultaneous quantification of these alkaloids in rat plasma and was applied to a toxicokinetic study. Chromatographic separation was achieved on a reversed-phase C18 column using gradient elution with aqueous and organic mobile phases containing a volatile acid modifier. Detection was performed by electrospray ionization in the positive ion mode with multiple reaction monitoring, and plasma samples were prepared by protein precipitation. The method was validated according to the current bioanalytical guidelines. The calibration curves showed good linearity (r > 0.99) over the tested ranges, the intra- and inter-run accuracy and precision were within ±15% (±20% at lower limit of quantification (LLOQ)), and the selectivity, carry-over, recovery, matrix effect, dilution integrity, and stability were acceptable. The LLOQs were 10 ng/mL for arecoline and guvacoline, and 100 ng/mL for arecaidine. The validated method was successfully applied for a toxicokinetic study in rats, and plasma concentration–time profiles of all analytes were characterized. These results show that the developed method is suitable for the quantitative determination of arecoline, arecaidine, and guvacoline in plasma and can be used in toxicokinetic and pharmacokinetic studies.
- 18 May 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessDevelopment and Application of a Liquid Chromatography–Tandem Mass Spectrometry Method for the Analysis of Areca Nut Alkaloids in Rat Plasma for a Toxicokinetic Study
Areca nut (Areca catechu L., Arecaceae) contains bioactive alkaloids, including arecoline, arecaidine, and guvacoline, which are associated with pharmacological and toxicological effects. A rapid and sensitive ultra-performance liquid chromatography–tandem mass spectrometry (UPLC–MS/MS) method was developed and validated for simultaneous quantification of these alkaloids in rat plasma and was applied to a toxicokinetic study. Chromatographic separation was achieved on a reversed-phase C18 column using gradient elution with aqueous and organic mobile phases containing a volatile acid modifier. Detection was performed by electrospray ionization in the positive ion mode with multiple reaction monitoring, and plasma samples were prepared by protein precipitation. The method was validated according to the current bioanalytical guidelines. The calibration curves showed good linearity (r > 0.99) over the tested ranges, the intra- and inter-run accuracy and precision were within ±15% (±20% at lower limit of quantification (LLOQ)), and the selectivity, carry-over, recovery, matrix effect, dilution integrity, and stability were acceptable. The LLOQs were 10 ng/mL for arecoline and guvacoline, and 100 ng/mL for arecaidine. The validated method was successfully applied for a toxicokinetic study in rats, and plasma concentration–time profiles of all analytes were characterized. These results show that the developed method is suitable for the quantitative determination of arecoline, arecaidine, and guvacoline in plasma and can be used in toxicokinetic and pharmacokinetic studies.
- Open Access
- 16 January 2026
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 209 (3)
The International Collaborative Animal Study of the carcinogenicity and genotoxicity of mobile phone radiofrequency radiation: the Korean study
A chronic bioassay investigating radiofrequency (RF) carcinogenicity, intentionally designed to be conducted simultaneously in Korea and Japan, using the same research protocol and experimental environment. The study aimed to assess the potential carcinogenicity of Code Division Multiple Access (CDMA)-modulated 900 MHz RF signals at a whole-body specific absorption rate (SAR) of 4 W/kg, which is the reference level of the international human safety guideline, and to verify the key findings from the National Toxicology Program (NTP) study at that SAR level. Two reverberation chamber systems were used for RF exposures, and the same study protocols were followed. Male Harlan Sprague–Dawley (Hsd:Sprague Dawley SD) rats were randomly assigned to cage-control, sham-exposed, or RF-exposed groups. The exposure started on gestational day 5 and lasted for 18 h and 20 min each day, with 10-min on/off cycles. The project included a 28-d toxicity study, a 2-yr carcinogenicity study, and a 14-wk genotoxicity test. Histopathological evaluations were conducted in a partially blinded manner. The results were independently analyzed and submitted separately based on each country’s research findings. In the Korean study, no statistically significant changes in tumor incidence or survival rates were observed. No significant RF-related effects were detected in the heart, brain, or adrenal glands. No changes in body temperature. Genotoxicity tests showed no evidence of DNA damage or mutation. In conclusion, the Korean part found that long-term exposure to CDMA-modulated 900 MHz RF was neither carcinogenic nor genotoxic at a SAR of 4 W/kg in male rats. An international animal study was jointly conducted as a chronic bioassay in Japan and Korea to evaluate the carcinogenicity of mobile phone RF signals and to verify key findings from the NTP study using identical protocols and exposure systems.
- 16 January 2026
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 209 (3)
Open AccessThe International Collaborative Animal Study of the carcinogenicity and genotoxicity of mobile phone radiofrequency radiation: the Korean study
A chronic bioassay investigating radiofrequency (RF) carcinogenicity, intentionally designed to be conducted simultaneously in Korea and Japan, using the same research protocol and experimental environment. The study aimed to assess the potential carcinogenicity of Code Division Multiple Access (CDMA)-modulated 900 MHz RF signals at a whole-body specific absorption rate (SAR) of 4 W/kg, which is the reference level of the international human safety guideline, and to verify the key findings from the National Toxicology Program (NTP) study at that SAR level. Two reverberation chamber systems were used for RF exposures, and the same study protocols were followed. Male Harlan Sprague–Dawley (Hsd:Sprague Dawley SD) rats were randomly assigned to cage-control, sham-exposed, or RF-exposed groups. The exposure started on gestational day 5 and lasted for 18 h and 20 min each day, with 10-min on/off cycles. The project included a 28-d toxicity study, a 2-yr carcinogenicity study, and a 14-wk genotoxicity test. Histopathological evaluations were conducted in a partially blinded manner. The results were independently analyzed and submitted separately based on each country’s research findings. In the Korean study, no statistically significant changes in tumor incidence or survival rates were observed. No significant RF-related effects were detected in the heart, brain, or adrenal glands. No changes in body temperature. Genotoxicity tests showed no evidence of DNA damage or mutation. In conclusion, the Korean part found that long-term exposure to CDMA-modulated 900 MHz RF was neither carcinogenic nor genotoxic at a SAR of 4 W/kg in male rats. An international animal study was jointly conducted as a chronic bioassay in Japan and Korea to evaluate the carcinogenicity of mobile phone RF signals and to verify key findings from the NTP study using identical protocols and exposure systems.
- Open Access
- 12 January 2026
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 209 (3)
The International Collaborative Animal Study of mobile phone radiofrequency radiation carcinogenicity and genotoxicity: the Japanese study
The potential carcinogenic and genotoxic effects of radiofrequency electromagnetic fields, particularly those emitted by mobile communication systems, have raised public health concerns. A previous study by the U.S. National Toxicology Program suggested increased incidences of gliomas and cardiac schwannomas in rats exposed to high levels of RF radiation. To evaluate these findings, an international collaborative study was initiated between Japan and Korea. Male Hsd:Sprague Dawley SD rats were exposed to 900 MHz CDMA-modulated RF-EMFs at a whole-body specific absorption rate of 4 W/kg for 18 h and 20 min daily over 2 yr. The study included a 28-d preliminary toxicity study, genotoxicity assays (alkaline comet and micronucleus tests), and a 2-yr carcinogenicity assessment. All procedures followed OECD guidelines and Good Laboratory Practice. No statistically significant increases in the incidences of neoplastic or non-neoplastic lesions were found in any major organ, including the brain, heart, and adrenal glands. Genotoxicity assays revealed no evidence of DNA damage or chromosomal aberrations in RF-exposed rats. A higher survival rate in the RF-exposed group, likely due to lower body weight and food consumption, was observed. This study, performed in Japan, jointly planned and executed by Japan and Korea, provides strong evidence that long-term exposure to 900 MHz RF-EMFs did not produce reproducible carcinogenic or genotoxic effects in male rats. Combined with data from the Korean counterpart study, these results are expected to contribute to future international assessments of the carcinogenic potential of electromagnetic radiation.
- 12 January 2026
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 209 (3)
Open AccessThe International Collaborative Animal Study of mobile phone radiofrequency radiation carcinogenicity and genotoxicity: the Japanese study
The potential carcinogenic and genotoxic effects of radiofrequency electromagnetic fields, particularly those emitted by mobile communication systems, have raised public health concerns. A previous study by the U.S. National Toxicology Program suggested increased incidences of gliomas and cardiac schwannomas in rats exposed to high levels of RF radiation. To evaluate these findings, an international collaborative study was initiated between Japan and Korea. Male Hsd:Sprague Dawley SD rats were exposed to 900 MHz CDMA-modulated RF-EMFs at a whole-body specific absorption rate of 4 W/kg for 18 h and 20 min daily over 2 yr. The study included a 28-d preliminary toxicity study, genotoxicity assays (alkaline comet and micronucleus tests), and a 2-yr carcinogenicity assessment. All procedures followed OECD guidelines and Good Laboratory Practice. No statistically significant increases in the incidences of neoplastic or non-neoplastic lesions were found in any major organ, including the brain, heart, and adrenal glands. Genotoxicity assays revealed no evidence of DNA damage or chromosomal aberrations in RF-exposed rats. A higher survival rate in the RF-exposed group, likely due to lower body weight and food consumption, was observed. This study, performed in Japan, jointly planned and executed by Japan and Korea, provides strong evidence that long-term exposure to 900 MHz RF-EMFs did not produce reproducible carcinogenic or genotoxic effects in male rats. Combined with data from the Korean counterpart study, these results are expected to contribute to future international assessments of the carcinogenic potential of electromagnetic radiation.
- Open Access
- 5 January 2026
- Published by Wiley in Environmental Toxicology
- Vol. 41 (9) , 670-681
Preclinical Toxicity Screening of Sodium Dodecanoyloxybenzenesulfonate ( LOBS ) as a New Alternative Biocide Using In Vitro and In Vivo Models
Sodium hypochlorite is a well‐established biocide extensively used in both living and industrial environments; however, exposure to it or improper handling can harm the human body and the environment. Thus, safer alternatives to sodium hypochlorite are required. Therefore, the objective of this research was to assess the genotoxicity, cardiotoxicity, 2‐week repeated‐dose toxicity studies (oral, dermal), and acute irritation/corrosion of sodium dodecanoyloxybenzenesulfonate (LOBS), a new alternative biocide in various biological systems. LOBS did not show genotoxic or cardiotoxic effects in the bacterial reverse mutation test, chromosomal aberration test, or hERG assay. Both males and females showed an increase in U‐Na levels ( p < 0.01), while an increase in focus/foci, thickness in the stomach, and discoloration was observed in the thymus of males during the 2‐week repeated oral‐dose toxicity study. In the 2‐week repeated dermal‐dose toxicity study, no significant adverse effects were observed. While mild erythema and edema were observed in all animals during the acute dermal irritation/corrosion study, all the animals recovered. During the acute eye irritation/corrosion study, all animals showed mild corneal clouding, conjunctival redness, and conjunctival chemosis; however, all animals recovered. Moreover, LOBS was classified into category 3 (mild irritant) and category 2A (irritant) in the acute dermal and eye irritation/corrosion studies. Therefore, LOBS should be further developed as a potential alternative biocide to sodium hypochlorite.
- 5 January 2026
- Published by Wiley in Environmental Toxicology
- Vol. 41 (9) , 670-681
Open AccessPreclinical Toxicity Screening of Sodium Dodecanoyloxybenzenesulfonate ( LOBS ) as a New Alternative Biocide Using In Vitro and In Vivo Models
Sodium hypochlorite is a well‐established biocide extensively used in both living and industrial environments; however, exposure to it or improper handling can harm the human body and the environment. Thus, safer alternatives to sodium hypochlorite are required. Therefore, the objective of this research was to assess the genotoxicity, cardiotoxicity, 2‐week repeated‐dose toxicity studies (oral, dermal), and acute irritation/corrosion of sodium dodecanoyloxybenzenesulfonate (LOBS), a new alternative biocide in various biological systems. LOBS did not show genotoxic or cardiotoxic effects in the bacterial reverse mutation test, chromosomal aberration test, or hERG assay. Both males and females showed an increase in U‐Na levels ( p < 0.01), while an increase in focus/foci, thickness in the stomach, and discoloration was observed in the thymus of males during the 2‐week repeated oral‐dose toxicity study. In the 2‐week repeated dermal‐dose toxicity study, no significant adverse effects were observed. While mild erythema and edema were observed in all animals during the acute dermal irritation/corrosion study, all the animals recovered. During the acute eye irritation/corrosion study, all animals showed mild corneal clouding, conjunctival redness, and conjunctival chemosis; however, all animals recovered. Moreover, LOBS was classified into category 3 (mild irritant) and category 2A (irritant) in the acute dermal and eye irritation/corrosion studies. Therefore, LOBS should be further developed as a potential alternative biocide to sodium hypochlorite.
- Open Access
- 1 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-15
Efficacy and safety of a novel multivalent mRNA vaccine against SARS-CoV-2 in experimental animals
The mRNA vaccine is an innovative new platform that can be developed rapidly, offering a robust tool to managing infectious diseases like COVID-19. However, non-clinical evaluations are essential for safety use. In this study, the efficacy, general toxicity, and safety pharmacology of a novel multivalent mRNA-encapsulated lipid nanoparticle (LNP) vaccine (RGV-DO-003) were evaluated using a focus reduction neutralization test (FRNT), virus challenge test, single- and repeated-dose studies, immunogenicity tests, and neurobehavioral, body temperature, respiratory, and cardiovascular system assessments in experimental animals. The administration route was intramuscular, and the vaccine doses were 5 and 50 μg/head for each efficacy test and toxicity study. Neutralizing antibodies were observed in the vaccinated group through FRNT and virus challenge tests. Macroscopic observations revealed a tendency for the lung lesion area to decrease in the vaccinated group. In the general toxicity study, mild symptoms were observed at the injection site in the vaccine administration group. Immunogenicity analysis revealed an increase in the binding antibody titer in the vaccine-administered group. Safety pharmacology study revealed no significant toxicological changes associated with LNP or vaccine administration. Overall, the RGV-DO-003 mRNA vaccine is effective and safe under experimental conditions, suggesting it is a potential candidate for clinical trials.
- 1 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-15
Open AccessEfficacy and safety of a novel multivalent mRNA vaccine against SARS-CoV-2 in experimental animals
The mRNA vaccine is an innovative new platform that can be developed rapidly, offering a robust tool to managing infectious diseases like COVID-19. However, non-clinical evaluations are essential for safety use. In this study, the efficacy, general toxicity, and safety pharmacology of a novel multivalent mRNA-encapsulated lipid nanoparticle (LNP) vaccine (RGV-DO-003) were evaluated using a focus reduction neutralization test (FRNT), virus challenge test, single- and repeated-dose studies, immunogenicity tests, and neurobehavioral, body temperature, respiratory, and cardiovascular system assessments in experimental animals. The administration route was intramuscular, and the vaccine doses were 5 and 50 μg/head for each efficacy test and toxicity study. Neutralizing antibodies were observed in the vaccinated group through FRNT and virus challenge tests. Macroscopic observations revealed a tendency for the lung lesion area to decrease in the vaccinated group. In the general toxicity study, mild symptoms were observed at the injection site in the vaccine administration group. Immunogenicity analysis revealed an increase in the binding antibody titer in the vaccine-administered group. Safety pharmacology study revealed no significant toxicological changes associated with LNP or vaccine administration. Overall, the RGV-DO-003 mRNA vaccine is effective and safe under experimental conditions, suggesting it is a potential candidate for clinical trials.
- Open Access
- 28 May 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 350, 120064
Comparative study on the toxicity of Polygoni Multiflori Radix: Assessment of decoction extract and powder in single-dose and 13-week repeated-dose toxicity studies in Sprague-Dawley rats
- 28 May 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 350, 120064
Open AccessComparative study on the toxicity of Polygoni Multiflori Radix: Assessment of decoction extract and powder in single-dose and 13-week repeated-dose toxicity studies in Sprague-Dawley rats
- 26 February 2025
- Published by Springer Nature in Toxicological Research
- Vol. 41 (3) , 279-290
Toxicity of diclofenac sodium salt after two weeks of daily intramuscular administration in cynomolgus monkeys
Diclofenac sodium salt (DSS) has been extensively studied in pharmacological research to better understand its pain relief and inflammation-reducing properties. However, it is crucial to evaluate the safety profile of this non-steroidal anti-inflammatory drug, particularly in nonhuman primates (NHPs), such as cynomolgus monkeys. Understanding the potential adverse effects and toxicity of DSS in NHP is critical for determining their overall safety and use in clinical settings. Further investigation into its toxicity to NHPs would provide valuable information for developing and using this drug in medical practice. Our aim was to evaluate the toxicity of DSS administered repeatedly to cynomolgus monkeys to identify its safety profile in NHPs. The general toxicity of DSS was established using a 2-week repeated-dose toxicity test. Twenty-four cynomolgus monkeys were intramuscularly injected with 0, 0.33, 1, and 3 mg/kg of DSS each day. This study assessed the potential adverse effects and toxicity of DSS in these monkeys, providing valuable data for understanding its safety in clinical settings. The 2-week repeated-dose toxicity study of DSS revealed no treatment-related changes in body weight, food consumption, ophthalmology, or general symptoms. Furthermore, no significant changes were observed in hematological, clinical chemistry, or urinalysis data. Histopathological examination revealed decreased cellularity (lymphocytes) in both the thymus and spleen (white pulp). The sternal bone marrow had a higher cell count than usual. Furthermore, mixed cell and mononuclear cell infiltration, inflammation, myofiber degeneration, and muscle fiber necrosis were observed at the injection site (skin), but these findings were not considered adverse effects. Notably, the no observed adverse effect level of DSS was estimated to be greater than 3 mg/kg in both males and females. Therefore, this study established a non-toxic dose of DSS, laying the groundwork for further nonclinical studies to assess the safety of DSS using NHP.
- 26 February 2025
- Published by Springer Nature in Toxicological Research
- Vol. 41 (3) , 279-290
Toxicity of diclofenac sodium salt after two weeks of daily intramuscular administration in cynomolgus monkeys
Diclofenac sodium salt (DSS) has been extensively studied in pharmacological research to better understand its pain relief and inflammation-reducing properties. However, it is crucial to evaluate the safety profile of this non-steroidal anti-inflammatory drug, particularly in nonhuman primates (NHPs), such as cynomolgus monkeys. Understanding the potential adverse effects and toxicity of DSS in NHP is critical for determining their overall safety and use in clinical settings. Further investigation into its toxicity to NHPs would provide valuable information for developing and using this drug in medical practice. Our aim was to evaluate the toxicity of DSS administered repeatedly to cynomolgus monkeys to identify its safety profile in NHPs. The general toxicity of DSS was established using a 2-week repeated-dose toxicity test. Twenty-four cynomolgus monkeys were intramuscularly injected with 0, 0.33, 1, and 3 mg/kg of DSS each day. This study assessed the potential adverse effects and toxicity of DSS in these monkeys, providing valuable data for understanding its safety in clinical settings. The 2-week repeated-dose toxicity study of DSS revealed no treatment-related changes in body weight, food consumption, ophthalmology, or general symptoms. Furthermore, no significant changes were observed in hematological, clinical chemistry, or urinalysis data. Histopathological examination revealed decreased cellularity (lymphocytes) in both the thymus and spleen (white pulp). The sternal bone marrow had a higher cell count than usual. Furthermore, mixed cell and mononuclear cell infiltration, inflammation, myofiber degeneration, and muscle fiber necrosis were observed at the injection site (skin), but these findings were not considered adverse effects. Notably, the no observed adverse effect level of DSS was estimated to be greater than 3 mg/kg in both males and females. Therefore, this study established a non-toxic dose of DSS, laying the groundwork for further nonclinical studies to assess the safety of DSS using NHP.
- Open Access
- 19 January 2024
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 325, 117783
Evaluating the toxicity of the roots of Asarum heterotropoides var. mandshuricum extracted using the decoction method: Genotoxicity, single-dose toxicity, and 13-week repeated-dose toxicity studies
- 19 January 2024
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 325, 117783
Open AccessEvaluating the toxicity of the roots of Asarum heterotropoides var. mandshuricum extracted using the decoction method: Genotoxicity, single-dose toxicity, and 13-week repeated-dose toxicity studies